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INTRODUCTION
Metastatic bone disease is the most common ma-
lignant neoplasia of the skeleton, the bone being 
the third most common site of the spread of ade-
nocarcinomas, preceded only by the lung and the li-
ver(1). Bone’s predisposition to metastases is explai-
ned by the high blood flow under low pressure in 
the areas of red marrow and because bone matrix is 
a fertile ground for the implantation of tumor cells(2). 
Advances in adjuvant and neoadjuvant therapy, parti-
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ABSTRACT
Objective: To assess the early complications in the or-
thopedic treatment of metastatic bone lesions and the 
factors associated with these complications. Method: 
There were assessed, retrospectively, 64 patients that un-
derwent surgical treatment for bone metastases, analyzing 
the complications that occurred in the pre-operative and 
early post- operative period and associating them with the 
tumor origin, type of procedure done, the need of blood 
reposition before the surgery, the need of new surgical 
procedures and the mortality due to the complications. 
Results: Early complications in the treatment were obser-
ved in 17 (26.6%) patients, of which six (35.2%) ended 
up dying due to these complications. Regarding the type, 
15 (23.8%) cases were due to surgical complications, 
four (6.3%) clinical and three (4.7%) patients showed 
clinical and surgical complications. There was no sig-
nificant difference in the frequency of complications or 
mortality when assessed the type of reconstruction or 
affected region. The tumors with a renal origin needed 
more blood reposition and showed a bigger frequency of 
complications. Conclusion: The complications occurred 
in 26.6%. The complications are not related to the kind 
of treatment performed or to the region affected. The 
renal origin tumors showed a higher risk of hemorrhage.
Keywords – Bone neoplasms; Oncology; Fractures, spon-
taneous; Postoperative complications; orthopedic surgery
cularly hormone therapy and chemotherapy, have im-
proved the survival of cancer patients and increased 
the prevalence of patients living with bone metastases 
(BM). This makes control of BM a key factor in impro-
ving the quality of life, pain control, and in maintaining 
patient independence(1,3).
Although most cases of BM are treated clinically, 
orthopedic follow-up is able to identify lesions early that 
compromise the mechanical stability of the skeleton, 
preventing or treating fractures, controlling pain, and 
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reducing morbidity(3). Besides prevention, orthopedic 
treatment can restore the ability to walk in 94% of pa-
tients with pathological fracture(2).
The complications of this treatment are common and 
influenced by the patient’s clinical conditions, stage of 
disease, and the surgical procedure. They can occur peri-
operatively, in the immediate postoperative period, or 
in the late postoperative period and include clinical and 
surgical complications(1-3).
The aim of this study is to evaluate the early compli-
cations of patients undergoing orthopedic treatment of 




We reviewed the medical records of patients regis-
tered at the Department of Orthopedic Oncology, Hospi-
tal das Clínicas, Universidade Federal de Minas Gerais 
(UFMG) and Santa Casa de Belo Horizonte between 
January 2002 and March 2007 who underwent orthope-
dic surgical treatment of bone injuries secondary to ex-
traskeletal malignant neoplasia. The study was approved 
by the ethics committee of the respective hospitals. The 
study included 64 from a total of 90 patients. Twenty-
six patients were excluded due to insufficient data in 
the medical record (n = 12) and exclusion of tumors of 
medullary origin: multiple myeloma (n = 9), leukemia 
(n = 3), and lymphomas (n = 2).
The average age was 56.63 ± 14.26 years (29 to 85 
years), and 23 (35.9%) of the patients were males and 
41 were females (64.1%). Twelve (18.8%) patients were 
melanoderm, 24 (37.5%) were Mulatto and 28 (43.8%) 
were Caucasian. The mean survival was 9.20 ± 11.96 
months (median 6.6 months).
Radiotherapy was previously performed in 27 
(42.1%) patients and chemotherapy was previous-
ly performed in 56 (87.5%) patients. The reason for 
referral to orthopedic treatment was fracture in 42 
(65.6%) patients, pain in 20 (31.2%), and changes in 
tests in asymptomatic patients in two (3.2%) cases.
Tumors
All BM located in the limbs, pelvic and scapular gir-
dle, and requiring surgical treatment were included in the 
study. Primary bone tumors and those of medullary origin 
were excluded in the study. Regarding the organ of origin, 
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the most common was the breast tumor in 23 (35.9%) pa-
tients (Table 1). Regarding the histological type, the BM 
were adenocarcinomas in 34 (53.1%) cases, carcinoma 
in 23 (35.9%) patients, sarcomas in five (7.8%), and in 
two (3.1%) the cell type was undetermined.









BREAST 23 35.9 35.9
RENAL 8 12.5 48.4
PROSTATE 8 12.5 60.9
LUNG 4 6.3 67.2
COLORECTAL 4 6.3 73.4
THYROID 3 4.7 78.3
OTHER 12 18.8 96.9
UNKNOWN 2 3.1 100
TOTAL 64 100 100
 
Source: SAME, Hospital das Clínicas, UFMG, Santa Casa, BH.
The most common site was the lower limbs in 52 
(81.3%) patients, seven cases were located in the pelvis 
(10.9%), and five (7.9%) in the upper limbs. The lesions 
were solitary in 22 (34.3%) patients and in multiple 
locations in the skeleton in 42 (65.7%) (Table 2).
Orthopedic treatment
The indications for orthopedic surgery were patho-
logical fractures in 43 (67.2%) patients, impending frac-
tures in 17 (26.6%), and simple tumor resection with 
curative goal in four (5.3%).
The goal of surgery was the rigid stabilization of es-
tablished or impending fracture, allowing for the imme-
diate ambulation of the patient when possible, or wide 
resection of the lesion with a curative goal in isolated 
lesions without other organs affected and with a good 
oncological prognosis. Arthroplasties (conventional, 
hemiarthroplasty, and endoprostheses) were performed 
in 24 (37.5%) patients, osteosynthesis (plates and intra-
medullary nails) was performed in 36 (56.3%) and four 
(6.3%) did not undergo reconstruction (Table 3).
The mean preoperative blood hemoglobin concentra-
tion was 10.2 ± 1.9 mg/dL and the average perioperative 
replacement concentration of red blood cells was 1.48 ± 
1.2 units per patient (range from zero to six units); only 
17 (26.6%) patients did not require replacement.
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 Complications
All complications that occurred perioperatively and 
in the first month after surgery were evaluated, separated 
into clinical and surgical. Clinical complications included 
the systemic consequences of treatment and surgical 
complications were due to local effects during the 
operative procedure and the first 30 postoperative days. 
We analyzed the frequency of complications, mortality, 
the need for blood replacement measured by the number 
of units of packed red blood cells used in the perioperative 
and the need for additional surgical procedures.
These data were correlated with the following parame-
ters: the origin of the tumor, the type of procedure performed 
(arthroplasty X osteosynthesis), the location of the lesion 
(lower limbs X upper limbs) and the specific surgical site.
 
Statistical analysis
Data were analyzed using SPSS® software 12.0 (Chi-
cago, USA). Univariate analysis was performed using 
chi-square (x2) for qualitative variables or Fisher’s exact 
test when one of the frequencies was less than five. 
For quantitative variables we used analysis of variance 
(ANOVA), considering p values  < 0.05 as significant.
RESULTS
At the time of the study, 33 (51.6%) patients had 
progressed to death. Of the 64 patients who underwent 
Table 3 – Methods of fixation and reconstruction used in the 









PLATE + PMMA 23 35.9 35.9
IMN + PMMA 11 17.2 53.1
TOTAL PROSTHESIS 9 14.1 67.2
ENDOPROSTHESIS 13 20.3 87.5
HEMIARTHROPLASTY 2 3.1 90.6
ISOLATED PLATE 1 1.6 92.1
ISOLATED IMN 1 1.6 93.7
RESECTION 4 6.3 100.0
TOTAL 64 100.0 100.0
Legend: PMMA – polymethylmethacrylate, IMN – intramedullary nail.
Source: SAME, Hospital das Clínicas, UFMG, Santa Casa, BH.
surgical treatment for bone metastases, 17 (26.6%) 
had some early complication in the treatment, and six 
(35.2%) died as a result of this complication. Surgical 
complications were observed in ten (15.6%) patients, 
clinical complications in four (6.3%), and three cases 
(4.7%) had both clinical and surgical complications. Of 
the patients who developed complications, four (23.5%) 
required a new surgical procedure.
The clinical complications observed were deep 
vein thrombosis (n = 3), pulmonary thromboembolism 
(n = 1), acute myocardial infarction (n = 1), and pneu-
monia (n = 2). As for surgical complications, the most 
frequent was bleeding (n = 8), superficial infections 
(n = 2), deep infection (n = 1), dislocation of the pros-
thesis (n = 1), and breach of osteosynthesis (n = 1) 
(Figure 1).
When comparing the type of surgical procedure, 
five (20.8%) patients undergoing arthroplasty and 11 
(30.5%) undergoing osteosynthesis presented compli-
cations, a difference that is not significant (p = 0.404). 
Regarding mortality, two (8.3%) patients undergoing 
arthroplasty and three (8.3%) undergoing osteosynthesis 
died, a difference that is not significant (p = 1.000).
The average number of units of red blood cell replace-
ment was 1.54 unit in the group undergoing arthroplasty 
and 1.44 unit in the osteosynthesis group, a difference 
that is not significant (p = 0.759). When the primary tu-
mor was evaluated, tumors of a renal origin showed an 
increased risk of perioperative red blood cell replacement 
in comparison with other tumors (p = 0.0001).
As for the location of the lesion in the skeleton, there 
were no significant differences; surgical procedures 
Table 2 – Anatomical distribution of lesions submitted to surgical 









PELVIS 7 10.9 10.9
FEMORAL NECK 7 10.9 21.9
TROCHANTER 25 39.1 60.9




DISTAL FEMUR 2 3.1 90.6







DISTAL HUMERUS 1 1.6 100.0
TOTAL 64 100.0 100.0
Source: SAME, Hospital das Clínicas, UFMG, Santa Casa, BH.
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performed on the lower limbs resulted in 16 (27.1%) com-
plications and were observed in one (20%) patient with 
upper limb injuries (p = 0.890). When evaluating each 
specific operative site, despite the trend toward greater 
frequency of complications in the subtrochanteric region, 
there was no significant difference (p = 0.079).
Figure 1 – Postoperative complication characterized by breach of oste-
osynthesis and refracture after three weeks of surgery.
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DISCUSSION
Orthopedic treatment aims at controlling pain, 
stabilizing impending or pathologic fractures, 
maintaining mobility, gait, and preventing the 
complications of prolonged recumbency(1,3-5).
Surgical treatment options include conventional 
prostheses, endoprostheses, simple or associated os-
teosynthesis with use of polymethylmethacrylate (bone 
cement) and, more rarely, amputation. The choice of 
procedure depends on the condition of the patient, the 
extent of disease, and the site involved(1,4,5).
Postoperative complications are more frequent in 
these patients, who are usually debilitated, malnour-
ished, and who have metabolic and hematological 
disorders(1,6).
Harrington et al.(2) analyzed 375 pathological frac-
tures by BM and observed as complications: 13 infec-
tions, 11 thromboembolic complications, two cases of 
disseminated intravascular coagulation and one case of 
metastatic spread on the surgical site.
Park et al.(7) observed that in 58 patients undergoing 
surgical treatment of BM with arthroplasty infection 
occurred in 8.6% of cases and dislocation in 12.9% in 
the first two postoperative months.
Thai et al.(8), evaluating 96 BM surgeries of the hu-
merus, found radial nerve palsy to be the most common 
complication, in 6% of cases, and as a clinical complica-
tion, pulmonary thromboembolism in two cases.
In our study we observed a relatively high incidence 
of complications (26.6%) compatible with most of the 
series studied(3-6), with surgical complications being the 
most common, especially hemorrhage. The occurrence 
of increased bleeding is due to hypervascularity, sys-
temic effects of the tumor and of the chemotherapy and 
radiotherapy(1,5). The tumors of renal origin presented 
significant risk of hemorrhage and required more blood 
replacement than other tumors, which suggests the need 
for routine preoperative embolization.
Infections occurred in 4.8% of cases, which is con-
sistent with other studies in the literature(4-10). Jacofsky 
et al.(11), evaluating 42 cases of hip arthroplasty for the 
treatment of primary and metastatic malignant tumors, 
found deep infection to be the most common compli-
cation, with an incidence of almost 10% of the series.
Mechanical failure of the reconstruction was ob-
served in one case of osteosynthesis of a subtrochanteric 
fracture. Because the proximal femur is a region of high 
mechanical stress, several authors have suggested that 
the reconstruction should be done with unconventional 
prostheses, avoiding the complications of osteosynthesis 
indications(7,10,11), as seen in Figure 1.
From a clinical standpoint, the most common compli-
cation was thromboembolism, which occurred in 7.7% 
of cases, with one case of massive pulmonary embolism 
resulting in death in the immediate postoperative period. 
These findings are similar to those observed by Marco 
et al.(9), which reported deep vein thrombosis and su-
perficial infections as being responsible for 67% of the 
early complications of surgical treatment of acetabular 
BM. Nathan et al.(12) suggest that pharmacological pro-
phylaxis in these patients should be complemented by 
the use of mechanical methods due to the high risk of 
venous thrombosis.
In our series, complications were frequent and re-
sulted in 35.2% deaths and 23.5% new surgical interven-
tions, which suggests that they are usually more severe 
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and with increased morbidity in these patients.
Most studies do not compare the early complications 
between the different orthopedic procedures(8-10), and 
the evaluations are made from the point of view of the 
function and the late failure of the fixation method. Our 
study focused only early complications, in order to com-
pare the magnitude of the surgery and its consequences 
in patients with metastatic disease. Unlike some studies 
that suggest a lower rate of complications with the use 
of arthroplasty when compared with osteosynthesis(8-10), 
our study showed no difference in the incidence of com-
plications, mortality, or the need for blood replacement, 
suggesting that both procedures are compatible in terms 
of perioperative complications.
CONCLUSION
The incidence of complications associated with the 
orthopedic treatment of BM was 26.6%, with 35.2% 
mortality; bleeding, infection, and thromboembolic 
events were the most frequent complications. The com-
plications do not depend on the type of procedure or the 
area affected. The tumors of renal origin had a higher 
risk of bleeding and hemorrhage.
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